Phase 2a Study of HPG1860 in Subjects With NASH

NCT05338034 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

89

Enrollment

INDUSTRY

Sponsor class

Conditions

NASH - Nonalcoholic Steatohepatitis

Interventions

DRUG: HPG1860
DRUG: Placebo

Sponsor

Hepagene (Shanghai) Co., Ltd.